SBL
GH icon

Sargent Bickham Lagudis’s Guardant Health GH Stock Holding History

Sargent Bickham Lagudis’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.72K Hold
100
– – ﹤0.01% 876
2022
Q3 		$5K Hold
100
– – ﹤0.01% 782
2022
Q2 		$4K Hold
100
– – ﹤0.01% 825
2022
Q1 		$7K Buy
+100
New +$6.84K ﹤0.01% 749

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sargent Bickham Lagudis's GH Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Guardant Health (GH) position steady in Q4 2022 at 100 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #876.

Sargent Bickham Lagudis first reported a position in GH in Q1 2022 and has held it in 4 quarters since. The position peaked at $7K in Q1 2022. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Sargent Bickham Lagudis held 100 shares of Guardant Health worth $2.72K as of Q4 2022.
  • Sargent Bickham Lagudis left its Guardant Health share count unchanged in Q4 2022.
  • Guardant Health made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #876 holding.
  • Sargent Bickham Lagudis first reported a position in Guardant Health in Q1 2022 and has held it in 4 quarters since.
  • Sargent Bickham Lagudis's Guardant Health position peaked at $7K in Q1 2022.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.